Sutro Biopharma Inc (STRO) has released an update.
Sutro Biopharma, Inc. has been actively engaging in the sale of its common stock through a Sales Agreement with Jefferies LLC, successfully selling over $70 million worth of shares. The company has recently updated its shelf registration, allowing for an additional $100 million in shares to be offered. This move positions the company to potentially raise a significant sum, totaling up to approximately $129 million in share sales, which could interest investors looking for opportunities in the biopharmaceutical sector.
For further insights into STRO stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
